This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gomez-Manzano, C. Articles by Yung, W. K. A. Search for Related Content PubMed PubMed Citation Articles by Gomez-Manzano, C. Articles by Yung, W. K. A.

Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2¹

Departments of Neuro-Oncology [C. G-M., P. M., J. F., M. H., D. K., T. L. G., T-J. L., W. K. A. Y.], Thoracic and Head and Neck Medical Oncology [H-Y. L.], and Molecular Pathology [K. S., T. J. M.], The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030

Strong evidence exists to support the tenet that activation of E2F transcription factors, via alterations in the p16-cyclin D-Rb pathway, is a key event in the malignant progression of most human malignant gliomas. The oncogenic ability of E2F has been related to the E2F-mediated up-regulation of several proteins that positively regulate cell proliferation. However, E2F may indirectly enhance proliferation by activating antiapoptotic molecules. In this work, we sought to ascertain whether E2F-1-mediated events involve the up-regulation of the antiapoptotic molecule Bcl-2. Western blot analyses showed up-regulation of Bcl-2 but not of Bcl-x_L by 24 h after the transfer of E2F-1. Northern blot studies showed that transfer of E2F-1 also up-regulated Bcl-2 RNA. In support of these findings and the concept that E2F-1 has a direct effect in the induction of Bcl-2, we found a putative E2F binding site within the Bcl-2 sequence. Subsequent gel-mobility shift and supershift experiments involving the CTCCGCGC site in the bcl-2 promoter showed that E2F-1 bound Bcl-2. Transactivation experiments consistently showed that ectopic E2F-1 activated responsive elements located in the -1448/-1441 region in the P1 promoter region of the bcl-2 gene. As expected, other members of the E2F family of transcription factors such as E2F-2 and E2F-4 also transactivated the bcl-2 promoter. Our results demonstrate that E2F-1 modulates the expression of the antiapoptotic molecule Bcl-2 and suggest that up-regulation of Bcl-2 may favor the oncogenic role of E2F-1 and other members of the E2F family of transcription factors.

This article has been cited by other articles:

				M. I. Onyshchenko, T. I. Gaynutdinov, E. A. Englund, D. H. Appella, R. D. Neumann, and I. G. Panyutin Stabilization of G-quadruplex in the BCL2 promoter region in double-stranded DNA by invading short PNAs Nucleic Acids Res., December 1, 2009; 37(22): 7570 - 7580. [Abstract] [Full Text] [PDF]

				J. Dai, D. Chen, R. A. Jones, L. H. Hurley, and D. Yang NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region Nucleic Acids Res., October 6, 2006; 34(18): 5133 - 5144. [Abstract] [Full Text] [PDF]

				S. A. Vorburger, N. Hetrakul, W. Xia, M. Wilson-Heiner, N. Mirza, R. E. Pollock, B. Feig, S. G. Swisher, and K. K. Hunt Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo Mol. Cancer Ther., November 1, 2005; 4(11): 1710 - 1716. [Abstract] [Full Text] [PDF]

				T. Hershko and D. Ginsberg Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis J. Biol. Chem., March 5, 2004; 279(10): 8627 - 8634. [Abstract] [Full Text] [PDF]